Ionis Pharmaceuticals
IONS
IONS
359 hedge funds and large institutions have $6.17B invested in Ionis Pharmaceuticals in 2024 Q1 according to their latest regulatory filings, with 49 funds opening new positions, 123 increasing their positions, 128 reducing their positions, and 50 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
2.56% less ownership
Funds ownership: 100.12% → 97.56% (-2.6%)
15% less capital invested
Capital invested by funds: $7.27B → $6.17B (-$1.1B)
17% less funds holding in top 10
Funds holding in top 10: 6 → 5 (-1)
Holders
359
Holding in Top 10
5
Calls
$48.1M
Puts
$27.5M
Top Buyers
| 1 | +$46.8M | |
| 2 | +$31M | |
| 3 | +$29.7M | |
| 4 |
BNP Paribas Asset Management
Paris,
France
|
+$19M |
| 5 |
Artisan Partners
Milwaukee,
Wisconsin
|
+$18.1M |
Top Sellers
| 1 | -$44.1M | |
| 2 | -$43.8M | |
| 3 | -$40M | |
| 4 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$35.6M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$33.5M |